(Q46513051)

22 December 2017

title

Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines (English)

1 reference

22 December 2017

author

Peter-Michael Kloetzel

8

object named as

Peter-Michael Kloetzel

0 references

Ulrike Kuckelkorn

4

object named as

Ulrike Kuckelkorn

1 reference

22 December 2017

author name string

Hannes A Braun

1

1 reference

22 December 2017

Sumaira Umbreen

2

1 reference

22 December 2017

Michael Groll

3

1 reference

22 December 2017

Izabela Mlynarczuk

5

1 reference

22 December 2017

Moritz E Wigand

6

1 reference

22 December 2017

Ilse Drung

7

1 reference

22 December 2017

Boris Schmidt

9

1 reference

22 December 2017

language of work or name

English

0 references

publication date

26 May 2005

1 reference

22 December 2017

Journal of Biological Chemistry

published in

1 reference

22 December 2017

volume

280

1 reference

22 December 2017

issue

31

1 reference

22 December 2017

page(s)

28394-28401

1 reference

22 December 2017

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

The 26S proteasome: a molecular machine designed for controlled proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Structural features of the 26 S proteasome complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Structure and functions of the 20S and 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Structure of 20S proteasome from yeast at 2.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

The proteasome: paradigm of a self-compartmentalizing protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Antigen processing by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Proteasome inhibitors: from research tools to drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

The ubiquitin-proteasome pathway and proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Aspartic proteases involved in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Human β-Secretase (BACE) and BACE Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Preferential induction of apoptosis for primary human leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502453200

21 January 2018

Identifiers

DOI

10.1074/JBC.M502453200

1 reference

22 December 2017

1 reference

22 December 2017